AvroBio Inc
AVROBIO, Inc. is a leading, Phase 2 gene therapy company focused on the development of its investigational gene therapy, AVR-RD-01, in Fabry disease, as well as additional gene therapy programs in other lysosomal storage disorders including Gaucher disease, cystinosis and Pompe disease. The Company’s plato™ platform includes a proprietary vector system, automated cell manufacturing solution and refined conditioning regimen deploying therapeutic drug monitoring. AVROBIO is headquartered in Cambridge, MA and has offices in Toronto, ON.
Current Price
$28.53
-1.69%AvroBio Inc (TECX) Stock Chart
TECX Interactive Stock Chart
Interactive stock chart for AvroBio Inc (TECX) with candlestick and line chart views. Analyze price action across multiple timeframes: 5 days, 1 week, 1 month, 3 months, 6 months, 1 year, 5 years, and full history.
Current price: $28.53. 52-week high: $35.87. 52-week low: $14.71. 50-day moving average: $29.53. 200-day moving average: $22.19.
Technical analysis indicators include Volume, SMA 20, SMA 50, SMA 200, EMA 20, and RSI. Toggle between candlestick and line chart styles. Overlay multiple moving averages to identify support and resistance levels, trend direction, and momentum signals for TECX. Use the chart alongside GoodMoat's fundamental analysis tools for a complete picture of AvroBio Inc's investment potential.